Integrase inhibitors
Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate
Composition
- Active ingredients
- DOLUTEGRAVIR 50MG; LAMIVUDINE 300MG; TENOFOVIR DISOPROXIL FUMARATE 300MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA209670.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate
- Active substance
- dolutegravir
- Drug class
- Integrase inhibitors, Antivirals for treatment of HIV infections, combinations
- Group
- Antivirals
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Mylan Pharms Inc